» Articles » PMID: 36308408

Incidence and Development of Cholestasis in Surgical Neonates Receiving an Intravenous Mixed-oil Lipid Emulsion

Abstract

Background: Intestinal failure-associated liver disease (IFALD), initially manifesting as cholestasis, is a complication in neonates receiving parenteral nutrition (PN). Soybean oil lipid emulsion (SOLE), though implicated in IFALD, was the only US Food and Drug Administration (FDA)-approved initial intravenous lipid emulsion (ILE) for infants and children in the United States. A mixed-oil lipid emulsion (MOLE) gained popularity in patients at risk for IFALD and was recently FDA approved as an initial ILE in children. Given the presence of soybean oil in MOLE, we hypothesized that MOLE would not be effective at preventing cholestasis in surgical neonates.

Methods: Neonates with gastrointestinal surgical conditions necessitating PN for ≥14 days and receiving MOLE (SMOFlipid) from July 2016 to July 2019 were analyzed retrospectively. Unpaired and pair-matched historical surgical neonates treated with SOLE (Intralipid) served as controls. The primary outcome measure was development of cholestasis (direct bilirubin ≥2 mg/dl).

Results: Overall, 63% (10 of 16) of MOLE patients and 22% (30 of 136) of SOLE patients developed cholestasis after ≥14 days of therapy (P = 0.005). The latency to developing cholestasis was significantly shorter in MOLE patients compared with SOLE patients.

Conclusion: In surgical neonates, MOLE may not prevent cholestasis and should not be considered hepatoprotective. Regardless of ILE source, all surgical neonates should be closely monitored for development of IFALD. To date, there is still no ILE able to prevent IFALD.

Citing Articles

Intravenous lipid emulsions designed to meet preterm infant requirements increase plasma and tissue levels of docosahexaenoic acid and arachidonic acid in mice.

Fligor S, Tsikis S, Hirsch T, Quigley M, Pan A, Kishikawa H Clin Nutr. 2024; 43(10):2273-2285.

PMID: 39213823 PMC: 11439576. DOI: 10.1016/j.clnu.2024.08.019.


Comparison of two formulations of intravenous lipid emulsions in pediatric intestinal failure.

Naik M, Lawrence A, Davidson A, Chapman J, Ferguson D, Speer A Pediatr Surg Int. 2024; 40(1):97.

PMID: 38581576 DOI: 10.1007/s00383-024-05674-4.


An Overview of Parenteral Nutrition from Birth to Adolescence Based on a Composite Fish Oil Containing Lipid Emulsion and a Pediatric Amino Acid Solution.

Goulet O Nutrients. 2024; 16(3).

PMID: 38337724 PMC: 10857063. DOI: 10.3390/nu16030440.


The Development of Magnolol-Loaded Intravenous Emulsion with Low Hepatotoxic Potential.

Gostynska A, Czerniel J, Kuzminska J, Zolnowska I, Brzozowski J, Krajka-Kuzniak V Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765070 PMC: 10537714. DOI: 10.3390/ph16091262.


A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.

Fligor S, Tsikis S, Hirsch T, Pan A, Moskowitzova K, Rincon-Cruz L Gastroenterology. 2023; 165(3):733-745.e9.

PMID: 37263310 PMC: 10527514. DOI: 10.1053/j.gastro.2023.05.035.

References
1.
Holman R . The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr. 1960; 70(3):405-10. DOI: 10.1093/jn/70.3.405. View

2.
Mascioli E, Lopes S, Champagne C, Driscoll D . Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition. 1996; 12(4):245-9. DOI: 10.1016/s0899-9007(96)90850-3. View

3.
Call L, Molina T, Stoll B, Guthrie G, Chacko S, Plat J . Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs. J Lipid Res. 2020; 61(7):1038-1051. PMC: 7328048. DOI: 10.1194/jlr.RA120000652. View

4.
Cober M, Killu G, Brattain A, Welch K, Kunisaki S, Teitelbaum D . Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr. 2011; 160(3):421-7. DOI: 10.1016/j.jpeds.2011.08.047. View

5.
Cober M, Teitelbaum D . Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant. 2010; 15(3):330-3. DOI: 10.1097/MOT.0b013e328338c2da. View